3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Neoplasms
3
Smoking Cessation
2
Smoking
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematopoietic and Lymphatic System Neoplasm
1
Depression
1
Colonic Neoplasms
1
Cancer Patients
1
Anxiety Disorders
1
Advanced Malignant Solid Neoplasm
1
Interventions
Paclitaxel
6
pembrolizumab
3
Cisplatin
3
Carboplatin
3
Biopsy
3
adavosertib
2
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
Fulvestrant
2
Doxorubicin
2
ulixertinib
1
tucatinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
selinexor
1
sapanisertib
1
sacituzumab govitecan
1
relugolix
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
niraparib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
dostarlimab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Mindfulness
×
1 year
×
Clear all
No trials found.